Enhabit (EHAB) Stock Forecast, Price Target & Predictions
EHAB Stock Forecast
Enhabit stock forecast is as follows: an average price target of $10.25 (represents a 26.54% upside from EHAB’s last price of $8.10) and a rating consensus of 'Hold', based on 5 wall street analysts offering a 1-year stock forecast.
EHAB Price Target
EHAB Analyst Ratings
Enhabit Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
May 14, 2024 | Whit Mayo | Leerink Partners | $8.50 | $8.64 | -1.62% | 4.94% |
Dec 08, 2022 | - | UBS | $12.00 | $13.99 | -14.22% | 48.15% |
Enhabit Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 1 |
Avg Price Target | - | - | $8.50 |
Last Closing Price | $8.10 | $8.10 | $8.10 |
Upside/Downside | -100.00% | -100.00% | 4.94% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
May 14, 2024 | Leerink Partners | - | Market Perform | Upgrade |
May 09, 2024 | Jefferies | - | Hold | Downgrade |
Mar 07, 2024 | UBS | Sell | Neutral | Upgrade |
Aug 11, 2023 | Credit Suisse | Neutral | Neutral | Hold |
Dec 13, 2022 | CJS Securities | - | Market Perform | Initialise |
Dec 08, 2022 | UBS | - | Sell | Initialise |
Oct 13, 2022 | Oppenheimer | - | Perform | Initialise |
Enhabit Financial Forecast
Enhabit Revenue Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $260.60M | $258.30M | - | $265.10M | $275.10M | $265.70M | - |
Avg Forecast | $285.68M | $277.64M | $275.37M | $281.65M | $279.59M | $273.48M | $269.94M | $269.76M | $269.52M | $261.77M | $267.33M | $268.45M | $260.16M | $265.32M | $273.51M | $271.45M | $267.86M | $266.45M | $268.18M |
High Forecast | $291.58M | $283.38M | $281.06M | $287.47M | $285.37M | $279.13M | $275.52M | $275.34M | $275.09M | $268.28M | $272.86M | $274.00M | $263.76M | $270.81M | $279.17M | $277.06M | $273.39M | $271.96M | $268.18M |
Low Forecast | $281.86M | $273.93M | $271.69M | $277.89M | $275.85M | $269.82M | $266.33M | $266.15M | $265.92M | $258.39M | $263.76M | $264.86M | $257.29M | $261.78M | $269.86M | $267.82M | $264.28M | $262.89M | $268.18M |
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 0.97% | - | 0.98% | 1.03% | 1.00% | - |
Enhabit EBITDA Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $12.60M | $15.60M | - | $22.00M | $36.80M | $25.90M | - |
Avg Forecast | $33.77M | $32.82M | $32.56M | $33.30M | $33.05M | $32.33M | $31.91M | $31.89M | $31.86M | $30.95M | $31.61M | $31.74M | $30.76M | $31.37M | $32.34M | $32.09M | $31.67M | $31.50M | $31.71M |
High Forecast | $34.47M | $33.50M | $33.23M | $33.99M | $33.74M | $33.00M | $32.57M | $32.55M | $32.52M | $31.72M | $32.26M | $32.39M | $31.18M | $32.02M | $33.00M | $32.76M | $32.32M | $32.15M | $31.71M |
Low Forecast | $33.32M | $32.39M | $32.12M | $32.85M | $32.61M | $31.90M | $31.49M | $31.47M | $31.44M | $30.55M | $31.18M | $31.31M | $30.42M | $30.95M | $31.90M | $31.66M | $31.24M | $31.08M | $31.71M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.41% | 0.50% | - | 0.69% | 1.16% | 0.82% | - |
Enhabit Net Income Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-6.40M | $-2.40M | - | $2.70M | $7.70M | $8.60M | - |
Avg Forecast | $6.20M | $4.92M | $5.80M | $5.43M | $3.88M | $1.75M | $3.38M | $2.81M | $4.87M | $2.27M | $2.86M | $2.33M | $1.26M | $3.05M | $6.75M | $7.71M | $11.65M | $14.50M | $24.70M |
High Forecast | $6.37M | $5.05M | $5.95M | $5.57M | $3.99M | $1.79M | $3.47M | $2.89M | $5.00M | $2.84M | $2.93M | $2.39M | $1.30M | $3.13M | $6.94M | $7.91M | $11.96M | $14.89M | $24.70M |
Low Forecast | $6.10M | $4.84M | $5.69M | $5.33M | $3.82M | $1.72M | $3.32M | $2.76M | $4.79M | $1.14M | $2.81M | $2.29M | $1.24M | $2.99M | $6.64M | $7.57M | $11.45M | $14.25M | $24.70M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -5.07% | -0.79% | - | 0.35% | 0.66% | 0.59% | - |
Enhabit SG&A Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $114.50M | $108.80M | - | $110.50M | $106.50M | $107.50M | - |
Avg Forecast | $112.88M | $109.71M | $108.81M | $111.29M | $110.48M | $108.06M | $106.66M | $106.59M | $106.50M | $103.44M | $105.63M | $106.07M | $102.80M | $104.84M | $108.08M | $107.26M | $105.84M | $105.29M | $105.97M |
High Forecast | $115.22M | $111.97M | $111.06M | $113.59M | $112.76M | $110.30M | $108.87M | $108.80M | $108.70M | $106.01M | $107.82M | $108.27M | $104.22M | $107.01M | $110.31M | $109.48M | $108.03M | $107.46M | $105.97M |
Low Forecast | $111.37M | $108.24M | $107.35M | $109.80M | $109.00M | $106.62M | $105.24M | $105.17M | $105.07M | $102.10M | $104.22M | $104.66M | $101.67M | $103.44M | $106.63M | $105.83M | $104.43M | $103.88M | $105.97M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.11% | 1.04% | - | 1.03% | 1.01% | 1.02% | - |
Enhabit EPS Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.13 | $-0.05 | - | $0.05 | $0.15 | $0.17 | - |
Avg Forecast | $0.12 | $0.10 | $0.12 | $0.11 | $0.08 | $0.03 | $0.07 | $0.06 | $0.10 | $0.05 | $0.06 | $0.05 | $0.03 | $0.06 | $0.13 | $0.15 | $0.23 | $0.29 | $0.49 |
High Forecast | $0.13 | $0.10 | $0.12 | $0.11 | $0.08 | $0.04 | $0.07 | $0.06 | $0.10 | $0.06 | $0.06 | $0.05 | $0.03 | $0.06 | $0.14 | $0.16 | $0.24 | $0.30 | $0.49 |
Low Forecast | $0.12 | $0.10 | $0.11 | $0.11 | $0.08 | $0.03 | $0.07 | $0.06 | $0.10 | $0.02 | $0.06 | $0.05 | $0.02 | $0.06 | $0.13 | $0.15 | $0.23 | $0.28 | $0.49 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -5.15% | -0.79% | - | 0.33% | 0.65% | 0.59% | - |
Enhabit Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
HCSG | Healthcare Services Group | $11.14 | $17.33 | 55.57% | Hold |
EHAB | Enhabit | $8.10 | $10.25 | 26.54% | Hold |
SEM | Select Medical | $35.23 | $40.00 | 13.54% | Buy |
INNV | InnovAge | $5.99 | $6.80 | 13.52% | Hold |
ACHC | Acadia Healthcare Company | $78.23 | $84.89 | 8.51% | Buy |
EHC | Encompass Health | $93.25 | $93.17 | -0.09% | Buy |
ADUS | Addus HomeCare | $130.13 | $123.00 | -5.48% | Buy |
PNTG | Pennant Group | $34.52 | $30.67 | -11.15% | Buy |
ENSG | Ensign Group | $152.73 | $114.25 | -25.19% | Buy |
EHAB Forecast FAQ
Is Enhabit a good buy?
No, according to 5 Wall Street analysts, Enhabit (EHAB) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 0 'Buy' recommendations, accounting for 0% of EHAB's total ratings.
What is EHAB's price target?
Enhabit (EHAB) average price target is $10.25 with a range of $8.5 to $12, implying a 26.54% from its last price of $8.1. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Enhabit stock go up soon?
According to Wall Street analysts' prediction for EHAB stock, the company can go up by 26.54% (from the last price of $8.1 to the average price target of $10.25), up by 48.15% based on the highest stock price target, and up by 4.94% based on the lowest stock price target.
Can Enhabit stock reach $12?
EHAB's average twelve months analyst stock price target of $10.25 does not support the claim that Enhabit can reach $12 in the near future.
What are Enhabit's analysts' financial forecasts?
Enhabit's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.09B (high $1.12B, low $1.08B), average EBITDA is $129.19M (high $131.86M, low $127.46M), average net income is $11.82M (high $12.14M, low $11.61M), average SG&A $431.8M (high $440.72M, low $426.02M), and average EPS is $0.236 (high $0.242, low $0.232). EHAB's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.12B (high $1.14B, low $1.11B), average EBITDA is $132.45M (high $135.19M, low $130.68M), average net income is $22.35M (high $22.95M, low $21.96M), average SG&A $442.69M (high $451.84M, low $436.77M), and average EPS is $0.446 (high $0.458, low $0.438).
Did the EHAB's actual financial results beat the analysts' financial forecasts?
Based on Enhabit's last annual report (Dec 2023), the company's revenue was $1.05B, which missed the average analysts forecast of $1.07B by -2.26%. Apple's EBITDA was $69.1M, missing the average prediction of $126.55M by -45.40%. The company's net income was $-80.5M, missing the average estimation of $18.77M by -528.91%. Apple's SG&A was $441.6M, beating the average forecast of $422.98M by 4.40%. Lastly, the company's EPS was $-1.61, missing the average prediction of $0.375 by -529.76%. In terms of the last quarterly report (Dec 2023), Enhabit's revenue was $260.6M, beating the average analysts' forecast of $260.16M by 0.17%. The company's EBITDA was $12.6M, missing the average prediction of $30.76M by -59.03%. Enhabit's net income was $-6.4M, missing the average estimation of $1.26M by -606.52%. The company's SG&A was $114.5M, beating the average forecast of $102.8M by 11.38%. Lastly, the company's EPS was $-0.13, missing the average prediction of $0.0252 by -615.46%